Olivier Sanchez

Active 1999–2025

120
Papers
24,600
Citations
61
h-index
115
i10-index

Citations

Citations per year for Olivier Sanchez1985: 1 citations1998: 2 citations1999: 2 citations2000: 1 citations2001: 6 citations2002: 11 citations2003: 13 citations2004: 13 citations2005: 19 citations2006: 39 citations2007: 37 citations2008: 74 citations2009: 59 citations2010: 88 citations2011: 68 citations2012: 64 citations2013: 67 citations2014: 107 citations2015: 89 citations2016: 135 citations2017: 105 citations2018: 154 citations2019: 537 citations2020: 749 citations2021: 878 citations2022: 634 citations2023: 455 citations2024: 828 citations2025: 267 citations2026: 54 citations1986–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,384 citing papers, 18.1% of this breakdownFrance: 623 citing papers, 8.1% of this breakdownItaly: 506 citing papers, 6.6% of this breakdownUnited Kingdom: 488 citing papers, 6.4% of this breakdownGermany: 486 citing papers, 6.4% of this breakdownCanada: 382 citing papers, 5% of this breakdownChina: 379 citing papers, 5% of this breakdownNetherlands: 367 citing papers, 4.8% of this breakdownSwitzerland: 320 citing papers, 4.2% of this breakdownSpain: 313 citing papers, 4.1% of this breakdownGreece: 173 citing papers, 2.3% of this breakdownBelgium: 167 citing papers, 2.2% of this breakdown
0%18.1%Other 26.8%

Fields

  • Medicine89.2%
  • Biochemistry, Genetics and Molecular Biology2.7%
  • Health Professions2.4%
  • Earth and Planetary Sciences1.6%
  • Engineering1.6%
  • Immunology and Microbiology1.1%
  • Other1.4%

Topics

  • Venous Thromboembolism Diagnosis and Management17.2%
  • Atrial Fibrillation Management and Outcomes7%
  • Pulmonary Hypertension Research and Treatments6.2%
  • COVID-19 Clinical Research Studies4.7%
  • Blood Coagulation and Thrombosis Mechanisms2.8%
  • Acute Myocardial Infarction Research2.4%
  • Other59.7%

Coauthors

All papers

Open in search
  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Felicita Andreotti, Emanuele Barbato, Johann Bauersachs, Andreas Baumbach, Farzin Beygui, Jørn Carlsen, Marco De Carlo, Marion Delcroix, Victoria Delgado, Pilar Escribano Subías, Donna Fitzsimons, Seán Gaine, Samuel Z. Goldhaber, Deepa Gopalan, Gilbert Habib, Sigrun Halvorsen, David P. Jenkins, Hugo A Katus, Barbro Kjellström, Mitja Lainščak, Patrizio Lancellotti, Geraldine Lee, Grégoire Le Gal, E. Messas, João Morais, Steffen E Petersen, Anna Sonia Petronio, Massimo Piepoli, Susanna Price, Marco Roffi, Aldo Salvi, Olivier Sanchez, Evgeny Shlyakhto, Iain A Simpson, Stefan Stortecky, Matthias Thielmann, Anton Vonk Noordegraaf, Cecilia Becattini, Héctor Bueno, Geert-Jan Geersing, Veli-Pekka Harjola, Menno V. Huisman, Marc Humbert, Catriona Jennings, David Jiménez, Nils Kucher, Iréne Lang, Mareike Lankeit, Roberto Lorusso, Lucia Mazzolai, Nicolas Meneveau, Fionnuala Ní Áinle, Paolo Prandoni, Piotr Pruszczyk, Marc Righini, Adam Torbicki, Eric VanBelle, José LuisZamorano, Stephan Windecker, Victor Aboyans, Colin Baigent, Jean‐Philippe Collet, Veronica Dean, Victoria Delgado, Donna Fitzsimons, Chris P Gale, Diederick E. Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung and 60 more - European Heart Journal 2019 cited by 4,777

  2. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Veronica Dean, Christi Deaton, Çetin Erol, Robert Fagard, Roberto Ferrari, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Patrizio Lancellotti, Aleš Linhart, Petros Nihoyannopoulos, Massimo Piepoli, Piotr Ponikowski, Per Anton Sirnes, Juan Tamargo, Michał Tendera, Adam Torbicki, William Wijns, Stephan Windecker, Document Reviewers, Çetin Erol, David Jiménez, Walter Ageno, Stefan Agewall, Riccardo Asteggiano, Rupert Bauersachs, Cecilia Becattini, Henri Bounameaux, Harry R. Büller, Constantinos H. Davos, Christi Deaton, Geert-Jan Geersing, Miguel Ángel Gómez Sánchez, Jeroen Hendriks, Arno W. Hoes, Mustafa Kılıçkap, Viacheslav Mareev, Manuel Monréal, João Morais, Petros Nihoyannopoulos, Bogdan A. Popescu, Olivier Sanchez, Alex C. Spyropoulos - European Heart Journal 2014 cited by 3,146

  3. Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. Poubeau, Grégoire Prévôt, Sébastien Renard, Martine Reynaud‐Gaubert, Marianne Riou, P. Roblot, Olivier Sanchez, Andrei Seferian, Cécile Tromeur, Jason Weatherald, Gérald Simonneau, David Montani, Marc Humbert, Olivier Sitbon - American Journal of Respiratory and Critical Care Medicine 2021 cited by 197

  4. Prediction of Pulmonary Embolism in the Emergency Department: The Revised Geneva Score

    Authors: , , , , , , - Annals of Internal Medicine 2006 cited by 1,096

  5. Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2014 cited by 941

  6. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis

    Authors: , , , , , , , - European Heart Journal 2014 cited by 592

  7. Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases

    Authors: , , , , , , , , , , , , , , , , , - European Respiratory Journal 2018 cited by 214

  8. Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabelle Mahé, Nicolas Falvo, Aurélien Delluc, Laurent Bertoletti, Christine Laneau, Aurélia Dinut, Philippe Aegerter, Joseph Emmerich, Hervé Decousus, Philippe Girard, E. Messas, Marie‐Pierre Revel, Anaïs Charles‐Nelson, Silvy Laporte, Laurent Bertoletti, Sandrine Acassat, Patrick Mismetti, C. Grangé, Guy Meyer, Benjamin Planquette, Olivier Sanchez, Isabelle Mahé, L. Plaisance, Géraldine Poénou, Gilles Pernod, B. Imbert, N. Zenati, Françis Couturaud, Emmanuelle Le Moigne, Raphaël Le Mao, Clément Hoffmann, Antoine Élias, Marie Elias, Nicolas Falvo, Romaric Loffroy, Maud Jandot, Marie‐Antoinette Sevestre, Santhi Samy Modéliar Rémond, Valérie Ray, Alexis Burnod, Pierre‐Marie Roy, Thomas Moumneh, Samir Henni, Nicolas Brebion, Miruna Timor-David, J. Constans, Carine Boulon, Sandro Aquilanti, D. Brisot, A. Bura-Rivière, Laurent Bertoletti, Françis Couturaud, Philippe Girard, Silvy Laporte, Isabelle Mahé, Guy Meyer, Patrick Mismetti, Benjamin Planquette, Olivier Sanchez - CHEST Journal 2021 cited by 159

  9. Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 339

  10. Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis

    Authors: , , , , , - European Heart Journal 2018 cited by 302

  11. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , N. Dublanchet, François-Xavier Lapébie, Nicolas Javaud, Alexandre Ghuysen, Mustapha Sebbane, Gilles Châtellier, Guy Meyer, David Jiménez, Menno V. Huisman, Olivier Sanchez, for the HOME-PE Study Group - European Heart Journal 2021 cited by 146

  12. Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Thrombosis and Haemostasis 2021 cited by 136

  13. Effect of a Retrievable Inferior Vena Cava Filter Plus Anticoagulation vs Anticoagulation Alone on Risk of Recurrent Pulmonary Embolism

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA 2015 cited by 485

  14. Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2017 cited by 347

  15. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism

    Authors: , , , , , , - European Respiratory Journal 2014 cited by 274

  16. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2011 cited by 588

  17. Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases

    Authors: , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2018 cited by 212

  18. Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2021 cited by 108

  19. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism

    Authors: , , , , , , , , , , - Thrombosis and Haemostasis 2014 cited by 345

  20. RETRACTED: Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Olivier Sanchez, Friedrich Grimminger, Matthias Held, Heinrike Wilkens, Stephan Rosenkranz, Ekkehard Grünig, Kristóf Karlócai, A Temesvári, István Édes, Sigita Aidietienė, Skaidrius Miliauskas, Tomás René Pulido Zamudio, Carlos Jerjes Sánchez, Anton Vonk Noordegraaf, Jerzy Lewczuk, Piotr Podolec, Jarosław D. Kasprzak, Tatiana Mularek‐Kubzdela, Ryszard Grzywna, Keertan Dheda, О. М. Моисеева, Alexander Chernyavskiy, В. М. Шипулин, О. Л. Барбараш, T. V. Martynyuk, Hyung‐Kwan Kim, Jun‐Bean Park, Jae Seung Lee, Rudolf Speich, Silvia Ulrich, John‐David Aubert, Arintaya Phrommintikul, Nattapong Jaimchariyatam, Suree Sompradeekul, Zeynep Pınar Önen, Gülfer Okumuş, Lyubomyr Solovey, Volodymyr Gavrysyuk, Luke Howard, Joanna Pepke‐Żaba, Robin Condliffe, John McConnell, Kim M. Kerr, Lan Hieu Nguyen, Nguyen Vinh Pham - The Lancet Respiratory Medicine 2017 cited by 264

  21. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2015 cited by 241

  22. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases

    Authors: , , , , , , - Human Pathology 2007 cited by 333

  23. Role of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial Hypertension

    Authors: , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2007 cited by 220

  24. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Angiogenesis 2021 cited by 203